8-K current report · filed Oct 28, 2026

Gossamer Bio, Inc. (GOSS) 8-K Current Report: October 28, 2026

Item 5.07GOSS overview

Short answer

Gossamer Bio, Inc. (GOSS) filed an 8-K current report with the SEC on October 28, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders approved potential share issuance exceeding 20% of pre-closing shares under the August 20, 2026 Purchase Agreement.

Gossamer Bio, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.07 · Submission of Matters to a Vote of Security Holders

  • Stockholders approved potential share issuance exceeding 20% of pre-closing shares under the August 20, 2026 Purchase Agreement
  • Approval covers Pre-Funded Warrants, FDA Approval Warrants, and Series A-1, A-2, and A-3 Preferred Stock conversions
  • Vote: 2,808,000 for, 37,814 against, and 29,441 abstentions
  • Authorization includes issuances to certain executive officers and directors, creating potential dilution and related-party considerations
  • Adjournment proposal was not needed after approval

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Gossamer Bio, Inc. 8-K filings

Get the next GOSS 8-K as it lands

Follow GOSS for push alerts, or ask the research agent what this filing means.